ストックスクリーナーアプリを入手
29.65
1.56%
-0.47
アフターアワーズ：
29.65
Veracyte Inc (VCYT) 最新ニュース
Veracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever! - Insider Monkey
9 AI News and Ratings on Investors’ Radar - Insider Monkey
Craig-Hallum bullish on Veracyte, initiates with a Buy - MSN
Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade - Yahoo
New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer - 01net
Veracyte Cancer Diagnostic Platform Shows Higher Specificity Than Blood Tests - Marketscreener.com
Veracyte (VCYT) Shares Cross Above 200 DMA - Nasdaq
Veracyte says new data demonstrate accuracy of WGS-based platform - TipRanks
New Data Demonstrate Accuracy Of Veracyte's Whole-Genome Sequencing-Based Mrd Testing Platform For Muscle-Invasive Bladder Cancer - Marketscreener.com
Revolutionary Blood Test Detects Cancer Return 3 Months Earlier Than Imaging - Stock Titan
5 Analysts Assess Veracyte: What You Need To Know - Benzinga
Craig-Hallum initiates Veracyte stock with Buy, sets $45 target By Investing.com - Investing.com South Africa
Craig-Hallum initiates Veracyte stock with Buy, sets $45 target - Investing.com India
Craig-Hallum Initiates Veracyte at Buy With $45 Price Target -March 20, 2025 at 07:28 am EDT - Marketscreener.com
Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25 - BioSpace
Veracyte's Decipher, MRD tests highlights to be presented at EAU25 -March 19, 2025 at 05:05 pm EDT - Marketscreener.com
Veracyte's Cancer Detection Tests Prove Powerful in Major Clinical StudiesNew Product Coming - StockTitan
Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally? - Yahoo Finance
Veracyte’s chief commercial officer John Leite sells $234,629 in stock By Investing.com - Investing.com Canada
Veracyte’s chief commercial officer John Leite sells $234,629 in stock - Investing.com
Veracyte (VCYT) Surged on Reporting Strong Earnings - Insider Monkey
Veracyte Inc to Host Earnings Call - ACCESS Newswire
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality - Simply Wall St
29,779 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Proficio Capital Partners LLC - Defense World
Veracyte at Raymond James Conference: Strategic Expansion and Growth By Investing.com - Investing.com Australia
Veracyte at Raymond James Conference: Strategic Expansion and Growth - Investing.com India
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com
Principal Financial Group Inc. Has $1.29 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - Simply Wall St
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Truist Financial Corp - Defense World
Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Veracyte (NASDAQ:VCYT) Given Buy Rating at Needham & Company LLC - MarketBeat
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
ARK Investment Management LLC Reduces Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Trading 9.9% Higher on Analyst Upgrade - MarketBeat
Guggenheim Reaffirms Buy Rating for Veracyte (NASDAQ:VCYT) - MarketBeat
Phocas Financial Corp. Reduces Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Shares Gap Down Following Weak Earnings - MarketBeat
VERACYTE, INC. SEC 10-K Report - TradingView
Rhumbline Advisers Purchases 675 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
StockNews.com Downgrades Veracyte (NASDAQ:VCYT) to Hold - Defense World
Veracyte (NASDAQ:VCYT) Cut to "Hold" at StockNews.com - MarketBeat
Investor Network: Veracyte Inc to Host Earnings Call - ACCESS Newswire
Veracyte’s Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
1.12%
1.76%
大文字化:
|
ボリューム (24 時間):